Vanadium-contaminated perioperatively administered infusion solutions and drugs

Biological Trace Element Research

Volumn 75, Issue 1-3, 2000, Pages 227-234

  Heinemann, Günter ^a   Vogt, Wolfgang ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Albumin solutions; Electrothermal atomic absorption spectrometry; Infusion solution therapy; Vanadium; Vanadium toxicity

Indexed keywords

VANADIUM;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD DONOR; CONTAMINATION; CRITICAL ILLNESS; GLOMERULUS FILTRATION RATE; HALF LIFE TIME; INFUSION; KIDNEY FUNCTION; NONHUMAN; PERIOPERATIVE PERIOD;

ALBUMINS; DRUG CONTAMINATION; HALF-LIFE; HEPARIN; INFUSIONS, INTRAVENOUS; INTRAOPERATIVE PERIOD; PHARMACEUTICAL SOLUTIONS; SPECTROPHOTOMETRY, ATOMIC; TRACE ELEMENTS; VANADIUM;

GLOMERULUS;

EID: 0033927701     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:75:1-3:227     Document Type: Article

References (24)

1. 1. F. H. Nielsen and E. O. Uthus, The essentiality and metabolism of vanadium, in Vanadium in Biological Systems, N. D. Chasteen, ed., Kluwer, Dordrecht, pp. 51-62 (1990).
2. 2. G. Heinemann and W. Vogt, Quantification of vanadium in serum by electrothermal atomic absorption spectrometry, Clin. Chem. 42, 1275-1282 (1996).
3. 3. N. Cohen, M. Halberstam, P. Shlimovich, C. J. Chang, H. Shamoon, and L. Rossetti, Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus, J. Clin. Invest. 95, 2501-2509 (1995).
4. 4. A. B. Goldfine, D. C. Simonson, F. Folli, M. E. Patti, and C. R. Kahn, Metabolic effects of sodium metavanadate in humans with insulin-dependent diabetes mellitus in vivo and in vitro studies, J. Clin. Endocrinol. Metab. 80, 3311-3320 (1995).
5. 5. G. Boden, X. Chen, J. Ruiz, G. D. van-Rossum, and S. Turco, Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus, Metabolism 45, 1130-1135 (1996).
6. 6. O. Ishida, K. Kihira, Y. Tsukamoto, and F. Marumo, Improved determination of vanadium in biological fluids by electrothermal atomic absorption spectrometry, Clin. Chem. 35, 127-130 (1989).
7. 7. Y. Tsukamoto, S. Saka, K. Kumano, S. Iwanami, O. Ishida, and F. Marumo, Abnormal accumulation of vanadium in patients on chronic hemodialysis therapy, Nephron 56, 368-373 (1990).
8. 8. U. Gafter, T. Malachi, H. Barak, and J. Levi, Red blood cell calcium level in chronic renal failure: effect of continous ambulatory peritoneal dialysis, J. Lab. Clin. Med. 116, 386-392 (1990).
9. 9. K. H. Schaller and G. Triebig, Vanadium, in Biological Indicators for the Assessment of Human Exposure to Industrial Chemicals, L. Alessio, A. Berlin, M. Boni, and R. Roi, eds., Commission of the European Communities, Ispra Establishment, Varese, pp. 78-93 (1987).
10. 10. T. D. Phillips, B. R. Nechay, and N. D. Heidelbaugh, Vanadium: chemistry and the kidney, Fed. Proc. 42, 2969-2973 (1983).
11. 11. S. Hosokawa and O. Yoshida, Vanadium in chronic hemodialysis patients, Int. J. Artif. Organs 13, 197-199 (1990).
12. 12. R. Cornelis, J. Versieck, L. Mees, J. Hoste, and F. Barbier, The ultratrace element vanadium in human serum, Biol. Trace Element Res. 3, 257-263 (1981).
13. 13. H. Sakurai, M. Nishida, M. Koyama, and J. Takada, Occurrence of vanadium ion in serum albumins, Biochem. Biophys. Acta 924, 562-563 (1987).
14. 14. G. Heinemann, S. Braun, M. Overbeck, M. Page, J. Michel, and W. Vogt, The effect of vanadium-contaminated commercially available albumin solutions on renal tubular function, Clin. Nephrol., in press.
15. 15. Ch. Westenfelder, R. K. Hamburger, and M. E. Garcia, Effect of vanadate on renal tubular function in rats, Am. J. Physiol. 240, F522-F529 (1981).
16. 16. Y. Higashi and E. Bello-Reuss, Effects of sodium orthovanadate on whole kidney and single nephron function, Kidney Int. 18, 302-308 (1980).
17. 17. P. Boscolo, M. Carmignani, A. R. Volpe, M. Felaco, G. del Rosso, G. Porcelli, et al., Renal toxicity and arterial hypertension in rats chronically exposed to vanadate, Occup. Environ. Med. 51, 500-503 (1994).
18. 18. E. Dafnis, M. Spohn, B. Lonis, N. A. Kurtzman, and S. Sabatini, Vanadate causes hypokalemic distal renal tubular acidosis, Am. J. Physiol. 262, F449-F453 (1992).
19. 19. J. J. Grantham, The renal sodium pump and vanadate, Am. J. Physiol. 239, F97-F106 (1980).
20. +-ATPase), Sem. Nephrol. 11, 37-44 (1991).
21. 21. J. J. Grantham and I. M. Glynn, Renal Na, K-ATPase: determinants of inhibition by vanadium, Am. J. Physiol. 236, F530-F535 (1979).
22. 22. T. Ramasarma and F. L. Crane, Does vanadium play a role in cellular regulation? Curr. Top. Cell Regul. 20, 247-301 (1981).
23. 23. G. R. Willsky, Vanadium in the biosphere, in Vanadium in Biological Systems, N. D. Chasteen, ed., Kluwer, Dordrecht, pp. 1-24 (1990).
24. 24. G. J. Quinlan, C. Coudray, A. Hubbard, and J. M. C. Gutteridge, Vanadium and copper in clinical solutions of albumin and their potential to damage protein structure, J. Pharm. Sci. 81, 611-614 (1992).